[1] Quinonez SC,Innis JW.Human HOX gene disorders［J］.Molecular Genetics and Metabolism,2014,111(1):4-15.
[2] Bhatlekar S,Fields JZ,Boman BM.HOX genes and their role in the development of human cancers［J］.J Molecular Medicine,2014,92(8):811-823.
[3] Collins CT,Hess JL.Role of HOXA9 in leukemia:Dysregulation,cofactors and essential targets［J］.Oncogene,2016,35(9):1090-1098.
[4] Liu Yuanyuan.Progress in relationship between HOXA9 gene and leukemia［J］.International J Pediatrics,2010,37(3):317-319.［刘媛媛.HOXA9基因与白血病关系的研究进展［J］.国际儿科学杂志,2010,37(3):317-319.］
[5] Popovic R,Erfurth F,Zeleznik-Le N.Transcriptional complexity of the HOXA9 locus［J］.Blood Cells,Molecules,and Diseases,2008,40(2):156-159.
[6] Lawrence HJ,Helgason CD,Sauvageau G,et al.Mice bearing a targeted interruption of the homeobox gene HOXA9 have defects in myeloid,erythroid,and lymphoid hematopoiesis［J］.Blood,1997,89(6):1922-1930.
[7] Panlo Menendez,Veronica Ramos-Mejia,Veronica Ayllon,et al.HOXA9 promotes hematopoietic commitment of human embryonic stem cells［J］.Exp Hematol,2014,42(8):S50.
[8] Brumatti G,Salmanidis M,Kok CH,et al.HoxA9 regulated Bcl-2 expression mediates survival of myeloid progenitors and the severity of HoxA9-dependent leukemia［J］.Oncotarget,2013,4(11):1933-1947.
[9] Bruhl T.Homeobox A9 transcriptionally regulates the EphB4 receptor to modulate endothelial cell migration and tube formation［J］.Circulation Research,2004,94(6):743-751.
[10] Gilbert PM,Mouw JK,Unger MA,et al.HOXA9 regulates BRCA1 expression to modulate human breast tumor phenotype［J］.J Clinical Investigation,2010,120(5):1535-1550.
[11] Alharbi RA,Pettengell R,Pandha HS,et al.The role of HOX genes in normal hematopoiesis and acute leukemia［J］.Leukemia,2013,27(5):1000-1008.
[12] Figueroa ME,Lugthart S,Li Y,et al.DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia［J］.Cancer Cell,2010,17(1):13-27.
[13] Collins C,Wang J,Miao H,et al.C/EBPalpha is an essential collaborator in Hoxa9/Meis1-mediated leukemogenesis［J］.Proc Natl Acad Sci USA,2014,111(27):9899-9904.
[14] Ayton PM,Cleary ML.Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9［J］.Genes Dev,2003,17(18):2298-2307.
[15] Saw J,Curtis DJ,Hussey DJ,et al.The fusion partner specifies the oncogenic potential of NUP98 fusion proteins［J］.Leuk Res,2013,37(12):1668-1673.
[16] Mullighan CG,Kennedy A,Zhou X,et al.Pediatric acute myeloid leukemia with NPM1 mutations is characterized by a gene expression profile with dysregulated HOX gene expression distinct from MLL-rearranged leukemias［J］.Leukemia,2007,21(9):2000-2009.
[17] Ortega S,Malumbres M,Barbacid M.Cyclin D-dependent kinases,INK4 inhibitors and cancer［J］.Biochim Biophys Acta,2002,1602(1):73-87.
[18] Wermuth PJ,Buchberg AM.Meis1-mediated apoptosis is caspase dependent and can be suppressed by coexpression of HoxA9 in murine and human cell lines［J］.Blood,2005,105(3):1222-1230.
[19] Costa BM,Smith JS,Chen Y,et al.Reversing HOXA9 oncogene activation by PI3K inhibition:Epigenetic mechanism and prognostic significance in human glioblastoma［J］.Cancer Res,2010,70(2):453-462.
[20] Verhaak RG,Hoadley KA,Purdom E,et al.Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA,IDH1,EGFR,and NF1［J］.Cancer Cell,2010,17(1):98-110.
[21] Pojo M,Goncalves CS,Xavier-Magalhaes A,et al.A transcriptomic signature mediated by HOXA9 promotes human glioblastoma initiation,aggressiveness and resistance to temozolomide［J］.Oncotarget,2015,6(10):7657-7674.
[22] Ota T,Klausen C,Clara Salamanca M,et al.Expression and function of HOXA genes in normal and neoplastic ovarian epithelial cells［J］.Differentiation,2009,77(2):162-171.
[23] Ko SY,Barengo N,Ladanyi A,et al.HOXA9 promotes ovarian cancer growth by stimulating cancer-associated fibroblasts［J］.J Clinical Investigation,2012,122(10):3603-3617.
[24] Ko SY,Naora H.HOXA9 promotes homotypic and heterotypic cell interactions that facilitate ovarian cancer dissemination via its induction of P-cadherin［J］.Mol Cancer,2014,13:170.
[25] Wrangle J,Machida EO,Danilova L,et al.Functional identification of cancer-specific methylation of CDO1,HOXA9,and TAC1 for the diagnosis of lung cancer［J］.Clin Cancer Res,2014,20(7):1856-1864.
[26] Hwang J,Lee BB,Kim Y,et al.HOXA9 inhibits migration of lung cancer cells and its hypermethylation is associated with recurrence in non-small cell lung cancer［J］.Molecular Carcinogenesis,2015,54(S1):E72-E80.
[27] Reynolds PA,Sigaroudinia M,Zardo G,et al.Tumor suppressor p16INK4A regulates polycomb-mediated DNA hypermethylation in human mammary epithelial cells［J］.J Biol Chem,2006,281(34):24790-24802.
[28] Park SY,Kwon HJ,Lee HE,et al.Promoter CpG island hypermethylation during breast cancer progression［J］.Virchows Arch,2011,458(1):73-84.
[29] Sun M,Song CX,Huang H,et al.HMGA2/TET1/HOXA9 signaling pathway regulates breast cancer growth and metastasis［J］.Proceedings of the National Academy of Sciences,2013,110(24):9920-9925.
[30] Lv J,Cao XF,Ji L,et al.Association of beta-catenin,Wnt1,Smad4,Hoxa9,and Bmi-1 with the prognosis of esophageal squamous cell carcinoma［J］.Med Oncol,2012,29(1):151-160.
[31] Sun X,Liu B,Ji W,et al.The role of HOXA9 in human laryngeal squamous cell carcinoma［J］.Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics,2012,20(10):467-472.
[32] Kim Y,Yoon H,Kim JS,et al.HOXA9,ISL1 and ALDH1A3 methylation patterns as prognostic markers for nonmuscle invasive bladder cancer:Array-based DNA methylation and expression profiling［J］.International J Cancer,2013,133(5):1135-1142.
[33] Kuo C,Lin C,Shih Y,et al.Frequent methylation of HOXA9 gene in tumor tissues and plasma samples from human hepatocellular carcinomas［J］.Clinical Chemistry and Laboratory Medicine（CCLM),2014,52(8):1235-1245.